Access to this symposium requires KEY ZONE access (paid
registration) to HDCN. For information about subscribing to HDCN,
please go to this link. |
Late-Breaking Clinical Trials
| Presentation and Speakers |
|
MP3 |
| Homocysteine-Lowering in Chronic Stable Renal Transplant Recipients: The FAVORIT Trial |
| Andrew G. Bostom, MD |
|
|
|
| Questions and Answers |
| Faculty |
|
|
|
| Selective Vitamin D Receptor Activator (VDRA) for Albuminuria Lowering (VITAL) Study in Type 2 Diabetic Nephropathy |
| Dick De Zeeuw, MD, PhD |
|
|
|
| Questions and Answers |
| Faculty |
|
|
|
| Trial to Reduce Cardiovascular Events With Aranesp Therapy |
| Marc Pfeffer, MD |
|
|
|
| Questions and Answers |
| Faculty |
|
|
|
| Prevention of Albuminuria and Cardiovascular Morbidity with Olmesartan: The ROADMAP Trial |
| Hermann G. Haller, MD |
|
|
|
| Questions and Answers |
| Faculty |
|
|
|
| Intensity of Renal Replacement Therapy in Critically ill Patients: The Randomized Evaluation of Normal versus Augmented Level Renal Replacement Therapy (RENAL) Study |
| Alan Cass, MBBS, PhD |
|
|
|
| Questions and Answers |
| Faculty |
|
|
|
|
Visit us next week for new topics !
|
|
